Source map — Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| The Guardian | news | 60% |
| Scientific American | news | 60% |
| Eli Lilly | news | 60% |
| Reuters | news | 60% |
| USA Today | news | 60% |
| Fierce Biotech | news | 60% |
| WSJ | news | 60% |
| CNBC | news | 60% |
| ScienceAlert | news | 60% |
| vialaudit.com | news | 50% |
| frnt.com | news | 50% |
| glp1watchdog.com | news | 50% |
| scitechdaily.com | news | 50% |
| puripharmacy.co.uk | news | 50% |
| www.aestheticsadvisor.com | news | 50% |
| medicalxpress.com | news | 50% |
| www.diabetes.co.uk | news | 50% |
| therxindex.com | social | 50% |
| peptidechecked.com | news | 50% |
| pharmaphorum.com | news | 50% |
| www.healthcount.app | news | 50% |
| www.news-age.com | news | 50% |
| www.onedaymd.com | news | 50% |
| theclinicaltimes.com | news | 50% |
| www.cerritosnewspaper.com | news | 50% |
| shotlee.app | news | 50% |
| www.dazzr.com | news | 50% |
| www.glp3.wiki | news | 50% |
| www.medicaldaily.com | news | 50% |
| www.sciencealert.com | news | 50% |